Stevanato Group’s (STVN) Equal Weight Rating Reaffirmed at Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Stevanato Group (NYSE:STVN) in a report released on Tuesday, Marketbeat.com reports. They currently have a $23.00 price target on the stock, down from their prior price target of $24.00.

Separately, Citigroup reduced their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 7th.

Stevanato Group Trading Up 0.1 %

Shares of NYSE:STVN opened at €20.07 ($21.13) on Tuesday. Stevanato Group has a fifty-two week low of €16.56 ($17.43) and a fifty-two week high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The firm’s 50-day simple moving average is €19.50 and its 200-day simple moving average is €19.59.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The business had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Stevanato Group’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.16 EPS. As a group, equities analysts predict that Stevanato Group will post 0.5 EPS for the current year.

Institutional Investors Weigh In On Stevanato Group

Institutional investors have recently modified their holdings of the company. Hardy Reed LLC grew its stake in Stevanato Group by 8.2% in the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock valued at $222,000 after acquiring an additional 840 shares during the last quarter. Lindenwold Advisors INC grew its position in shares of Stevanato Group by 13.5% in the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after purchasing an additional 1,415 shares during the last quarter. Captrust Financial Advisors increased its stake in shares of Stevanato Group by 12.7% during the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after purchasing an additional 1,480 shares in the last quarter. Raymond James Trust N.A. increased its stake in shares of Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after purchasing an additional 1,613 shares in the last quarter. Finally, First Bank & Trust lifted its stake in Stevanato Group by 29.1% in the 3rd quarter. First Bank & Trust now owns 14,109 shares of the company’s stock valued at $282,000 after buying an additional 3,182 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.